The Future of Mesothelioma Research
Mesothelioma is an aggressive cancer that isn’t researched as often as other types of cancer. A new study from the European Journal of Oncology Nursing explored what questions we still need to answer to provide the best care for mesothelioma patients. Screening and Preventative Tests Malignant mesothelioma is one of the rarest cancers in the US. That is fortunate because the cancer death rates from this malignancy continue to be very high. About 3,000 people receive a mesothelioma diagnosis every year – about 0.02% of all US cancer cases. Most newly diagnosed mesothelioma patients die within 18 months of diagnosis. Since mesothelioma is so rare, there isn’t as much research on this disease compared to more common cancers. This can…